Navigation Links
Pozen Announces Positive Outcome for PA 325

Administration, and with AstraZeneca for proprietary fixed dose combinations of naproxen with the proton pump inhibitor esomeprazole magnesium in a single tablet for conditions such as osteoarthritis and rheumatoid arthritis in patients who are at risk for developing NSAID-associated gastric ulcers. The company's common stock is traded on The

Nasdaq Stock Market under the symbol "POZN". For detailed company information, including copies of this and other press releases, see POZEN's website: *www.pozen.com*.

Statements included in this press release that are not historical in nature are "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. You should be aware that our actual results could differ materially from those contained in the forward-looking statements, which are based on management's current expectations and are subject to a number of risks and uncertainties, including, but not limited to, our failure to successfully commercialize our product candidates; costs and delays in the development and/or FDA approval of our product candidates, including as a result of the need to conduct additional studies, or the failure to obtain such approval of our product candidates, including as a result of changes in regulatory standards or the regulatory environment during the development period of any of our product candidates; uncertainties in clinical trial results or the timing of such trials, resulting in, among other things, an extension in the period over which we recognize deferred revenue or our failure to achieve milestones that would have provided us with revenue; our inability to maintain or enter into, and the risks resulting from our dependence upon, collaboration or contractual arrangements necessary for the development, manufacture, commercialization, marketing, sales and distribution of any products; competitiv
'"/>




Page: 1 2 3

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Pozen Announces Positive Outcome for
(Date:8/1/2014)... Aug. 1, 2014 In the latest call ... sexual dysfunction, more than 60 doctors and leading medical ... letter questioning the Food and Drug Administration,s (FDA) decision ... form of male sexual dysfunction compared with ZERO for ... to act for women by approving the first-ever drug ...
(Date:8/1/2014)... , Ill. and PALO ALTO, Calif. ... Fibrosis Research, Inc. (CFRI) today announced a partnership to ... fibrosis (CF) community through the CFChef Shares program. CFChef ... 2014, as part of AbbVie,s CFChef program – an ... encourage patients to maintain a healthy diet by submitting ...
(Date:8/1/2014)... Calif. , Aug. 1, 2014  Isis Pharmaceuticals, ... initiation of a pivotal Phase 3 study evaluating ISIS-SMN ... the most common genetic cause of infant mortality. Isis ... within the next few weeks, at which time Isis ... development partner, Biogen Idec. The Phase 3 study, ENDEAR, ...
Breaking Medicine Technology:60+ Doctors and Leading Medical Experts Sign an Open Letter Urging the FDA to Approve First-Ever Drug to Treat Women's Most Common Form of Sexual Dysfunction, notes Even the Score 260+ Doctors and Leading Medical Experts Sign an Open Letter Urging the FDA to Approve First-Ever Drug to Treat Women's Most Common Form of Sexual Dysfunction, notes Even the Score 3AbbVie and Cystic Fibrosis Research, Inc. (CFRI) Team Up to Raise Awareness of the Nutritional Needs of CF Patients through the CFChef Shares Program 2AbbVie and Cystic Fibrosis Research, Inc. (CFRI) Team Up to Raise Awareness of the Nutritional Needs of CF Patients through the CFChef Shares Program 3Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 2Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 3Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 4Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 5
... research sponsored by CVS Caremark examined the effects ... on medication adherence when the warnings are not ... that immediately following a high-profile FDA communication questioning ... level of patients who stopped filling their prescription ...
... 23 2012  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ... EAS 2012When:Friday, June 1st at 12:00 p.m. ET / ... our Web site listed above. If you are unable ... the webcast will be available for a limited time ...
Cached Medicine Technology:CVS Caremark Sponsored Research Finds FDA Drug Warnings Can Have Immediate Negative Impact on Medication Adherence, Even if Not Related to Safety 2CVS Caremark Sponsored Research Finds FDA Drug Warnings Can Have Immediate Negative Impact on Medication Adherence, Even if Not Related to Safety 3
(Date:8/1/2014)... benefits of a cancer diagnosis may improve health outcomes ... conducted by a researcher at the University of Houston ... writing intervention is the writing instruction. Otherwise, writing is ... a journal can be therapeutic, but oftentimes we don,t ... or not," said Qian Lu, assistant professor and director ...
(Date:8/1/2014)... 01, 2014 Hot off the presses after ... category of the World’s Best Awards by Travel + ... celebration of National Relaxation Day (technically August 15). , ... MAJOR experts to help guests celebrate relaxation throughout the month ... for health and wellness to carve out time to relax ...
(Date:8/1/2014)... Mozes HealthDay Reporter FRIDAY, ... serve as a time-honored destination for a good cut and ... might also be the spot to tackle an often overlooked ... a novel partnership, the U.S. Centers for Disease Control and ... enlisted the help of barbershop staff to both discuss and ...
(Date:8/1/2014)... August 01, 2014 For years, proponents ... A recent study conducted by the Ohio ... too far behind in terms of their health and ... know what’s best for their baby. So does this ... Dr. Steven Shapiro , chair of Pediatrics at ...
(Date:8/1/2014)... GlobalDatas new report, "United ... provides key market data on the United ... value, in millions of US dollars, volume ... dollars) within market segments - Electrosurgical RF ... Plasma Coagulation Generators. , To view the ...
Breaking Medicine News(10 mins):Health News:Expressive writing may help breast cancer survivors 2Health News:Expressive writing may help breast cancer survivors 3Health News:The Lodge at Woodloch Kicks Off National Relaxation Day with a Month Long Celebration 2Health News:The Lodge at Woodloch Kicks Off National Relaxation Day with a Month Long Celebration 3Health News:The Lodge at Woodloch Kicks Off National Relaxation Day with a Month Long Celebration 4Health News:Barbershops Join Fight Against High Blood Pressure in Black Men 2Health News:Barbershops Join Fight Against High Blood Pressure in Black Men 3Health News:Despite Recent Study, Abington Health Expert Encourages Breastfeeding 2Health News:Despite Recent Study, Abington Health Expert Encourages Breastfeeding 3Health News:United Kingdom Surgical Generators Market Size, Share, Analysis, Trends and Forecasts 2020 2Health News:United Kingdom Surgical Generators Market Size, Share, Analysis, Trends and Forecasts 2020 3
... and Drug Administration (FDA) has approved the NeuRx Diaphragm ... dependent on ventilators for breathing. The light-weight, battery-powered ... naturally, while eliminating the need for a power source ... was developed over the course of 20 years through ...
... safety program launched more than two years ago ... significantly improved communication between caregivers and patients and ... the program has found. , Children,s Hospital became ... with the Josie King Foundation to launch a ...
... proVision(TM) Now Manages Over 150,000 Identities, ANDOVER, ... the past six months, seven healthcare organizations have ... processes that eliminate the challenges of manual user ... (Nashville, TN) -- Baptist Health System (Birmingham, ...
... inspiring stories of Minnesotans who ... struggled to ... personally struggled to go smoke-free are sharing their,stories, from the time ... Their inspiring stories will be showcased in,ClearWay Minnesota,s traveling photo essay ...
... born by Caesarean section have a 50 % increased risk ... sections increase the risk even further. This is shown in ... registered at the Medical Birth Registry at the Norwegian Institute ... was to investigate the possible link between being born by ...
... CHAPEL HILL Psychosocial influences such as stress, depression ... studies involving people infected with HIV, yet they are ... individuals and the spread of AIDS, according to a ... , Now, a comprehensive update on those influences in ...
Cached Medicine News:Health News:FDA approves NeuRx diaphragm pacing system for use in spinal cord- injured patients 2Health News:Study finds Children's Hospital patient safety program improves caregiver/family communications 2Health News:Leading Healthcare Organizations Overwhelmingly Select Sentillion for User Provisioning 2Health News:Leading Healthcare Organizations Overwhelmingly Select Sentillion for User Provisioning 3Health News:In Smoke-Free Minnesota, Five Former Smokers Share Their Struggles With Fighting Addiction 2Health News:In Smoke-Free Minnesota, Five Former Smokers Share Their Struggles With Fighting Addiction 3Health News:In Smoke-Free Minnesota, Five Former Smokers Share Their Struggles With Fighting Addiction 4Health News:Caesarean sections associated with risk of asthma 2Health News:Psychosocial issues affect HIV/AIDS treatment outcomes: UNC researcher 2Health News:Psychosocial issues affect HIV/AIDS treatment outcomes: UNC researcher 3
... Parathyroid hormone (PTH) is synthesized ... secreted in response to decreased extracellular ... enhancing bone resorption and decreasing calcium ... into the circulation, intact PTH is ...
... the adrenal cortex and, to a lesser ... a precursor in testosterone and estrogen synthesis, ... at ~10% that of testosterone [1]. However, ... women, DHEA is an important androgen as ...
... steroid, is one of the most potent ... testosterone is secreted primarily by the testes ... peripheral conversion of androstenedione [2]. In adult ... 50% of serum testosterone is derived from ...
... Thyroxine (T4) is the primary active ... the thyroid gland [1]. T4 is synthesized ... iodide trapping by the follicular cells, (ii) ... substrate leading to formation of 3-monoiodotyrosine and ...
Medicine Products: